C135H147F15N26O14 — CID 158123478
(2S,4R)-N-[3-[2-(1,4-dioxan-2-yl)-6-morpholin-4-yl-4-pyridinyl]-4-methylphenyl]-2-(trifluoromethyl)piperidine-4-carboxamide;N-[3-[2-(3-hydroxypyrrolidin-1-yl)-6-morpholin-4-yl-4-pyridinyl]-4-methylphenyl]-2-(trifluoromethyl)pyridine-4-carboxamide;N-[5-[2-(3-hydroxypyrrolidin-1-yl)-6-morpholin-4-yl-4-pyridinyl]-6-methyl-3-pyridinyl]-3-(trifluoromethyl)benzamide;N-[4-methyl-3-(2-morpholin-4-yl-6-piperazin-1-yl-4-pyridinyl)phenyl]-2-(trifluoromethyl)pyridine-4-carboxamide;N-[6-methyl-5-(2-morpholin-4-yl-6-piperazin-1-yl-4-pyridinyl)-3-pyridinyl]-3-(trifluoromethyl)benzamide (PubChem CID 158123478) has the molecular formula C135H147F15N26O14 and a molecular weight of 2642.80 g/mol. Its IUPAC name is (2S,4R)-N-[3-[2-(1,4-dioxan-2-yl)-6-morpholin-4-yl-4-pyridinyl]-4-methylphenyl]-2-(trifluoromethyl)piperidine-4-carboxamide;N-[3-[2-(3-hydroxypyrrolidin-1-yl)-6-morpholin-4-yl-4-pyridinyl]-4-methylphenyl]-2-(trifluoromethyl)pyridine-4-carboxamide;N-[5-[2-(3-hydroxypyrrolidin-1-yl)-6-morpholin-4-yl-4-pyridinyl]-6-methyl-3-pyridinyl]-3-(trifluoromethyl)benzamide;N-[4-methyl-3-(2-morpholin-4-yl-6-piperazin-1-yl-4-pyridinyl)phenyl]-2-(trifluoromethyl)pyridine-4-carboxamide;N-[6-methyl-5-(2-morpholin-4-yl-6-piperazin-1-yl-4-pyridinyl)-3-pyridinyl]-3-(trifluoromethyl)benzamide.
| Compound Name | (2S,4R)-N-[3-[2-(1,4-dioxan-2-yl)-6-morpholin-4-yl-4-pyridinyl]-4-methylphenyl]-2-(trifluoromethyl)piperidine-4-carboxamide;N-[3-[2-(3-hydroxypyrrolidin-1-yl)-6-morpholin-4-yl-4-pyridinyl]-4-methylphenyl]-2-(trifluoromethyl)pyridine-4-carboxamide;N-[5-[2-(3-hydroxypyrrolidin-1-yl)-6-morpholin-4-yl-4-pyridinyl]-6-methyl-3-pyridinyl]-3-(trifluoromethyl)benzamide;N-[4-methyl-3-(2-morpholin-4-yl-6-piperazin-1-yl-4-pyridinyl)phenyl]-2-(trifluoromethyl)pyridine-4-carboxamide;N-[6-methyl-5-(2-morpholin-4-yl-6-piperazin-1-yl-4-pyridinyl)-3-pyridinyl]-3-(trifluoromethyl)benzamide |
|---|---|
| PubChem CID | 158123478 |
| Molecular Formula | C135H147F15N26O14 |
| Molecular Weight | 2642.80 g/mol |
| Exact Mass | 2641.14 |
| IUPAC Name | (2S,4R)-N-[3-[2-(1,4-dioxan-2-yl)-6-morpholin-4-yl-4-pyridinyl]-4-methylphenyl]-2-(trifluoromethyl)piperidine-4-carboxamide;N-[3-[2-(3-hydroxypyrrolidin-1-yl)-6-morpholin-4-yl-4-pyridinyl]-4-methylphenyl]-2-(trifluoromethyl)pyridine-4-carboxamide;N-[5-[2-(3-hydroxypyrrolidin-1-yl)-6-morpholin-4-yl-4-pyridinyl]-6-methyl-3-pyridinyl]-3-(trifluoromethyl)benzamide;N-[4-methyl-3-(2-morpholin-4-yl-6-piperazin-1-yl-4-pyridinyl)phenyl]-2-(trifluoromethyl)pyridine-4-carboxamide;N-[6-methyl-5-(2-morpholin-4-yl-6-piperazin-1-yl-4-pyridinyl)-3-pyridinyl]-3-(trifluoromethyl)benzamide |
| SMILES | Cc1ccc(NC(=O)[C@@H]2CCN[C@H](C(F)(F)F)C2)cc1-c1cc(C2COCCO2)nc(N2CCOCC2)c1.Cc1ccc(NC(=O)c2ccnc(C(F)(F)F)c2)cc1-c1cc(N2CCNCC2)nc(N2CCOCC2)c1.Cc1ccc(NC(=O)c2ccnc(C(F)(F)F)c2)cc1-c1cc(N2CCOCC2)nc(N2CCC(O)C2)c1.Cc1ncc(NC(=O)c2cccc(C(F)(F)F)c2)cc1-c1cc(N2CCNCC2)nc(N2CCOCC2)c1.Cc1ncc(NC(=O)c2cccc(C(F)(F)F)c2)cc1-c1cc(N2CCOCC2)nc(N2CCC(O)C2)c1 |
| InChI | InChI=1S/2C27H29F3N6O2.2C27H28F3N5O3.C27H33F3N4O4/c1-18-2-3-21(33-26(37)19-4-5-32-23(14-19)27(28,29)30)17-22(18)20-15-24(35-8-6-31-7-9-35)34-25(16-20)36-10-12-38-13-11-36;1-18-23(16-22(17-32-18)33-26(37)19-3-2-4-21(13-19)27(28,29)30)20-14-24(35-7-5-31-6-8-35)34-25(15-20)36-9-11-38-12-10-36;1-17-2-3-20(32-26(37)18-4-6-31-23(12-18)27(28,29)30)15-22(17)19-13-24(34-8-10-38-11-9-34)33-25(14-19)35-7-5-21(36)16-35;1-17-23(14-21(15-31-17)32-26(37)18-3-2-4-20(11-18)27(28,29)30)19-12-24(34-7-9-38-10-8-34)33-25(13-19)35-6-5-22(36)16-35;1-17-2-3-20(32-26(35)18-4-5-31-24(13-18)27(28,29)30)15-21(17)19-12-22(23-16-37-10-11-38-23)33-25(14-19)34-6-8-36-9-7-34/h2-5,14-17,31H,6-13H2,1H3,(H,33,37);2-4,13-17,31H,5-12H2,1H3,(H,33,37);2-4,6,12-15,21,36H,5,7-11,16H2,1H3,(H,32,37);2-4,11-15,22,36H,5-10,16H2,1H3,(H,32,37);2-3,12,14-15,18,23-24,31H,4-11,13,16H2,1H3,(H,32,35)/t;;;;18-,23?,24+/m....1/s1 |
| InChIKey | FRWNAKVUUDXQML-QHRFARMXSA-N |
| XLogP | 20.05 |
| TPSA | 431.83 Ų |
| H-Bond Donors | 10 |
| H-Bond Acceptors | 35 |
| Rotatable Bonds | 25 |
| Heavy Atoms | 190 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2642.80 |
| LogP ≤ 5 | 20.05 |
| H-Bond Donors ≤ 5 | 10 |
| H-Bond Acceptors ≤ 10 | 35 |